68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis

Autor: Stefano Fanti, Matteo Bardisserotto, George B Coura-Filho, Diego B Piant, Fabio Peroba Esteves, Bruna Macedo, Bruno Hochhegger, Ana Maria Marques da Silva, Gustavo do Vale Gomes, Cinthia Scatolin Tem-Pass, Ana Emília Brito, Eduardo Mundstock, Wanderley Marques Bernardo, Cristina Sebastião Matushita, Diego H. Roman, Phelipi Nunes Schuck, Juliano Julio Cerci, Jonatas L Pereira, Bárbara Juarez Amorim

Publikováno v: International Brazilian Journal of Urology, Vol 47, Iss 4, Pp 705-729 (2021)
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology
International braz j urol, Volume: 47, Issue: 4, Pages: 705-729, Published: 30 JUL 2021
International braz j urol v.47 n.4 2021
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU

Introduction: Prostate cancer (PC) is the second most commonly diagnosed cancer in males. 68Ga-PSMA PET/CT, a non-invasive diagnostic tool to evaluate PC with prostate-specific membrane antigen (PSMA) expression, has emerged as a more accurate altern

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab06fae0f3329c435fed31db11a2f207
https://doi.org/10.1590/s1677-5538.ibju.2019.0817

Comparison of CT and PET/CT for biopsy guidance in oncological patients

Autor: Juliano Julio Cerci, Mateos Bogoni, João V. Vitola, Stefano Fanti, Rodrigo Cerci, Carlos Pereira, Cassiano Krauzer, Danielle Giacometti Sakamoto, Elena Tabacchi, Dominique Delbeke

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging. 44:1269-1274

PURPOSE: To compare FDG PET/CT and CT for the guidance of percutaneous biopsies with histological confirmation of lesions. METHODS: We prospectively evaluated 323 patients of whom 181 underwent FDG PET/CT-guided biopsy (total 188 biopsies) and 142 un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a27da5ed4513865dc4b2dc80734e07
https://doi.org/10.1007/s00259-017-3658-8

Reply: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma

Autor: Francisca Redondo, Tamas Gyorke, Juliano Julio Cerci, Robert Carr, Stefano Fanti

Publikováno v: Journal of Nuclear Medicine. 56:164-164

164 Objectives Many of the >950 medical cyclotrons around the world today operate between 16 and 24 MeV, an ideal range for the production of 99mTc via the 100Mo(p,2n) reaction.1 Since 2010, our consortium has been studying the parameters for produci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0291a9e2388e1c95d995b6e39ffda2c7
https://doi.org/10.2967/jnumed.114.150086

Six country vignettes: Strengthening radiotherapy and theranostics.

Autor: Mikhail-Lette M; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria. Electronic address: M.Mikhail-Lette@iaea.org., Cordero L; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Lievens Y; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium., Al-Ibraheem A; Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Amman, Jordan., Urbain JL; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chera B; Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC, USA., Muylle K; Department of Nuclear Medicine, AZ Delta, Roselare, Belgium., Vaandering A; Department of Radiation Oncology, Université Catholique de Louvain, Saint-Luc University Hospital, Brussels, Belgium., Rosa AA; Department of Radiation Oncology, Oncoclínicas Salvador and Hospital Santa Izabel, Salvador, Bahia, Brazil., Cerci JJ; Department of Nuclear Medicine, Quanta Diagnóstico e Terapia, Curitiba, Brazil., Sathekge M; Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa., Minjgee M; National Cancer Center, Ulaanbaatar, Mongolia., Nansalmaa E; National Cancer Center, Ulaanbaatar, Mongolia., Erdenechimeg S; First State Central Clinic, National Medical University of Mongolia, Ulaanbaatar, Mongolia., Ruiz RL; Radiation Therapy Center Siglo 21, Hospital México and Clínica Bíblica, Caja Costarricense de Seguro Social, San Jose, Costa Rica., Scott A; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia., Paez D; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Giammarile F; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Veduta A; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Minoshima E; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Vichare S; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria., Abdel-Wahab M; International Atomic Energy Agency Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria.

Publikováno v: Journal of cancer policy [J Cancer Policy] 2024 Jun; Vol. 40, pp. 100471. Date of Electronic Publication: 2024 Mar 29.

Superfluous, controversial and luxury issues in nuclear medicine.

Autor: Ekmekcioglu O; Department of Nuclear Medicine, University of Health Sciences, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey., Terry SYA; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Morbelli S; IRCCS Ospedale San Martino, Genoa, Italy., Cerci JJ; Quanta - Diagnóstico e Terapia, Curitiba, Brazil., Zacho HD; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark., Peters S; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands., Chollet XB; Department of Nuclear Medicine, Centro Investigación Biomédica de La Rioja (CIBIR), La Rioja, Logroño, Spain., Verzijlbergen F; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands. fred.verzijlbergen@gmail.com.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (9), pp. 2582-2587.